{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52999"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52999","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"THE ROLE OF EARLY-LIFE GUT MICROBIOTA PROGRAMMING OF AIRWAY ALLERGIC RESPONSES AND AIRWAY HYPERRESPONSIVENESS","abstract":"Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Moya Uribe, Ivon Andrea"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Mansfield, Linda S","Ewart, Susan L","Wagner, James G","Moeser, Adam J"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:34Z","subjects":["Microbiology","Immunology","Physiology"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52999","local:MoyaUribe_grad.msu_0128D_22002"],"render_values":[{"text":"etd:52999","href":null,"code":true},{"text":"local:MoyaUribe_grad.msu_0128D_22002","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/gf64-nt28","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/gf64-nt28","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52999","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Mansfield, Linda S","Ewart, Susan L","Wagner, James G","Moeser, Adam J"]},{"key":"dc:creator","label":"Author","values":["Moya Uribe, Ivon Andrea"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Microbiology","Immunology","Physiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52999","local:MoyaUribe_grad.msu_0128D_22002","https://doi.org/doi:10.25335/gf64-nt28"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2026","Asthma is a chronic airway disease characterized by airway inflammation and airway hyperresponsiveness (AHR), which results in an exaggerated narrowing of the airways. Increasing evidence shows that the gut microbiota plays an important role in shaping immune responses and the risk of developing asthma. Several studies have demonstrated the existence of a gut-lung axis. However, the mechanisms linking gut microbes to lung function and allergic airway disease are not fully understood. In this dissertation, I investigated how early-life gut microbiota influences airway allergic responses and AHR and explored potential mechanisms underlying these effects.To address this, I used mouse models carrying different gut microbiotas, including conventional mouse microbiota (CM) and human-derived microbiotas from infants (INF A and INF B) and adults (Adult HU). Fecal microbiota transplantation (FMT) was performed into germ-free mice, and microbiotas were passed to offspring and the offspring studied to determine long-term effects. In Chapter II, mice were exposed to house dust mite (HDM) allergen to induce allergic airway disease. Lung function was assessed using the flexiVent system to measure baseline tissue mechanics and dose dependent responses to methacholine. In addition, inflammatory responses, immune markers such as total IgE, and microbial composition were evaluated. In Chapter III I investigated whether mast cells contributed to microbiota-driven differences in AHR by assessing mast cell markers at the protein, gene expression, and histological levels. In Chapter IV neonatal cross-fostering was used in a mouse model to evaluate an early-life intervention to prevent asthma and to document the role of a dysbiotic gut microbiota in asthma pathogenesis. Here, I exchanged the gut microbiota between CM and allergy-prone microbiota groups to assess the role of early microbial programming in increasing the risk of lung dysfunction and asthma or in preventing them. Across studies, mice carrying human-derived microbiotas showed impaired baseline lung function and increased airway hyperresponsiveness compared to mice with conventional microbiota, even in the absence of allergen exposure, demonstrating that gut microbiota alone can program airway dysfunction. These mice also had persistently elevated total IgE levels, suggesting a systemic immune effect linked to microbiota composition. Early-life microbial exposure was a critical determinant of these outcomes, as neonatal cross-fostering showed that exposure to protective microbiota reduced airway hyperresponsiveness while protective fecal microbiota transplant (FMT) in adulthood had limited effects. Despite these differences in lung function and IgE, mast cell activity did not differ between CM and INF A or INF B microbiota groups. Markers of mast cell activation, including protease expression and histological staining, were similar across groups, and mast cells were largely undetectable in lung tissue. These findings indicate that microbiota-driven increases in AHR occur independently of classical mast cell–mediated pathways suggesting that direct microbiota effects on lung innervation should be explored. Together, my work demonstrates that early-life gut microbiota plays a key role in programming airway function and susceptibility to allergic airway disease. The results support a model in which early-life gut microbiota programs airway hyperresponsiveness and allergic susceptibility through mechanisms likely involving alternative immune, epithelial, or neuro-immune pathways","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (277 p.) : ill."]},{"key":"dc:title","label":"Title","values":["THE ROLE OF EARLY-LIFE GUT MICROBIOTA PROGRAMMING OF AIRWAY ALLERGIC RESPONSES AND AIRWAY HYPERRESPONSIVENESS"]}]}],"canonical_facts":{"dc:contributor":["Mansfield, Linda S","Ewart, Susan L","Wagner, James G","Moeser, Adam J"],"dc:creator":["Moya Uribe, Ivon Andrea"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2026","Asthma is a chronic airway disease characterized by airway inflammation and airway hyperresponsiveness (AHR), which results in an exaggerated narrowing of the airways. Increasing evidence shows that the gut microbiota plays an important role in shaping immune responses and the risk of developing asthma. Several studies have demonstrated the existence of a gut-lung axis. However, the mechanisms linking gut microbes to lung function and allergic airway disease are not fully understood. In this dissertation, I investigated how early-life gut microbiota influences airway allergic responses and AHR and explored potential mechanisms underlying these effects.To address this, I used mouse models carrying different gut microbiotas, including conventional mouse microbiota (CM) and human-derived microbiotas from infants (INF A and INF B) and adults (Adult HU). Fecal microbiota transplantation (FMT) was performed into germ-free mice, and microbiotas were passed to offspring and the offspring studied to determine long-term effects. In Chapter II, mice were exposed to house dust mite (HDM) allergen to induce allergic airway disease. Lung function was assessed using the flexiVent system to measure baseline tissue mechanics and dose dependent responses to methacholine. In addition, inflammatory responses, immune markers such as total IgE, and microbial composition were evaluated. In Chapter III I investigated whether mast cells contributed to microbiota-driven differences in AHR by assessing mast cell markers at the protein, gene expression, and histological levels. In Chapter IV neonatal cross-fostering was used in a mouse model to evaluate an early-life intervention to prevent asthma and to document the role of a dysbiotic gut microbiota in asthma pathogenesis. Here, I exchanged the gut microbiota between CM and allergy-prone microbiota groups to assess the role of early microbial programming in increasing the risk of lung dysfunction and asthma or in preventing them. Across studies, mice carrying human-derived microbiotas showed impaired baseline lung function and increased airway hyperresponsiveness compared to mice with conventional microbiota, even in the absence of allergen exposure, demonstrating that gut microbiota alone can program airway dysfunction. These mice also had persistently elevated total IgE levels, suggesting a systemic immune effect linked to microbiota composition. Early-life microbial exposure was a critical determinant of these outcomes, as neonatal cross-fostering showed that exposure to protective microbiota reduced airway hyperresponsiveness while protective fecal microbiota transplant (FMT) in adulthood had limited effects. Despite these differences in lung function and IgE, mast cell activity did not differ between CM and INF A or INF B microbiota groups. Markers of mast cell activation, including protease expression and histological staining, were similar across groups, and mast cells were largely undetectable in lung tissue. These findings indicate that microbiota-driven increases in AHR occur independently of classical mast cell–mediated pathways suggesting that direct microbiota effects on lung innervation should be explored. Together, my work demonstrates that early-life gut microbiota plays a key role in programming airway function and susceptibility to allergic airway disease. The results support a model in which early-life gut microbiota programs airway hyperresponsiveness and allergic susceptibility through mechanisms likely involving alternative immune, epithelial, or neuro-immune pathways","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (277 p.) : ill."],"dc:identifier":["etd:52999","local:MoyaUribe_grad.msu_0128D_22002","https://doi.org/doi:10.25335/gf64-nt28"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Microbiology","Immunology","Physiology"],"dc:title":["THE ROLE OF EARLY-LIFE GUT MICROBIOTA PROGRAMMING OF AIRWAY ALLERGIC RESPONSES AND AIRWAY HYPERRESPONSIVENESS"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:34Z"}